Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pathophysiology of neurofibromatosis type 1.

Literature DB >> 16754926

Pathophysiology of neurofibromatosis type 1.

Amy Theos¹, Bruce R Korf.

Abstract

Entities: Gene

Mesh：

Year: 2006 PMID： 16754926 DOI： 10.7326/0003-4819-144-11-200606060-00010

Source DB: PubMed Journal: Ann Intern Med ISSN： 0003-4819 Impact factor: 25.391

Keyword Cloud
Cited

× No keyword cloud information.

45 in total

1. Von recklinghausens disease: a series of four cases with variable expression.

Authors: K P Arun; P Thomas Joseph; H P Jaishankar; M S Abhinethra
Journal: J Maxillofac Oral Surg Date: 2013-02-07

2. Teaching reading to children with neurofibromatosis type 1: a clinical trial with random assignment to different approaches.

Authors: Laura A Barquero; Angela M Sefcik; Laurie E Cutting; Sheryl L Rimrodt
Journal: Dev Med Child Neurol Date: 2015-04-22 Impact factor: 5.449

3. The effect of parental age on NF1 patients in Turkey.

Authors: P Sharafi; B Anlar; S Ersoy-Evans; A Varan; O F Yılmaz; M Turan; S Ayter
Journal: J Community Genet Date: 2017-11-15

4. PedsQL Neurofibromatosis Type 1 Module for children, adolescents and young adults: feasibility, reliability, and validity.

Authors: Kavitha Nutakki; James W Varni; Nancy L Swigonski
Journal: J Neurooncol Date: 2017-12-22 Impact factor: 4.130

5. MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.

Authors: Walter J Jessen; Shyra J Miller; Edwin Jousma; Jianqiang Wu; Tilat A Rizvi; Meghan E Brundage; David Eaves; Brigitte Widemann; Mi-Ok Kim; Eva Dombi; Jessica Sabo; Atira Hardiman Dudley; Michiko Niwa-Kawakita; Grier P Page; Marco Giovannini; Bruce J Aronow; Timothy P Cripe; Nancy Ratner
Journal: J Clin Invest Date: 2012-12-10 Impact factor: 14.808

Pathophysiology of neurofibromatosis type 1.

1. Von recklinghausens disease: a series of four cases with variable expression.

2. Teaching reading to children with neurofibromatosis type 1: a clinical trial with random assignment to different approaches.

3. The effect of parental age on NF1 patients in Turkey.

4. PedsQL Neurofibromatosis Type 1 Module for children, adolescents and young adults: feasibility, reliability, and validity.

5. MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.

6. Segmental neurofibromatosis: a report of 3 cases.

7. Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trends.

8. Plexiform neurofibroma in the hepatic hilum associated with neurofibromatosis type 1: a case report.

Review 9. [Type I neurofibromatosis and megadolichobasilar artery].

10. A case of neurofibromatosis 1 presenting with optic pathway glioma with an early onset and an aggressive course.